Femme et Homme
- | Pays :
- United Kingdom
- | Organes : -
- | Spécialités : -
Extrait
This is a study to investigate the efficacy and safety of epirubicin, cisplatin and capecitabine (ECX) as neoadjuvant therapy prior to radical chemoradiotherapy using capecitabine and cisplatin as radio-sensitisers in patients with newly diagnosed localized squamous cell carcinoma of the oesophagus.
Critère d'inclusion
- oesophageal carcinoma